栄研化学の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/08/04 | 1,876 | 1,892 | 1,855 | 1,882 | -4 | -0.2% | 92,600 |
| 2022/08/03 | 1,920 | 1,928 | 1,872 | 1,886 | -39 | -2% | 162,100 |
| 2022/08/02 | 1,974 | 1,982 | 1,924 | 1,925 | -59 | -3% | 153,400 |
| 2022/08/01 | 1,951 | 1,989 | 1,933 | 1,984 | +20 | +1% | 153,200 |
| 2022/07/29 | 1,997 | 2,009 | 1,953 | 1,964 | -45 | -2.2% | 280,100 |
| 2022/07/28 | 2,072 | 2,074 | 1,987 | 2,009 | -62 | -3% | 321,100 |
| 2022/07/27 | 1,926 | 2,076 | 1,918 | 2,071 | +157 | +8.2% | 588,000 |
| 2022/07/26 | 1,927 | 1,927 | 1,902 | 1,914 | -18 | -0.9% | 129,100 |
| 2022/07/25 | 1,936 | 1,951 | 1,930 | 1,932 | -4 | -0.2% | 126,800 |
| 2022/07/22 | 1,915 | 1,943 | 1,906 | 1,936 | +28 | +1.5% | 135,700 |
| 2022/07/21 | 1,875 | 1,913 | 1,869 | 1,908 | +26 | +1.4% | 111,200 |
| 2022/07/20 | 1,881 | 1,888 | 1,869 | 1,882 | +13 | +0.7% | 101,500 |
| 2022/07/19 | 1,882 | 1,882 | 1,855 | 1,869 | -27 | -1.4% | 67,600 |
| 2022/07/15 | 1,870 | 1,898 | 1,861 | 1,896 | +25 | +1.3% | 111,900 |
| 2022/07/14 | 1,862 | 1,871 | 1,849 | 1,871 | +9 | +0.5% | 101,600 |
| 2022/07/13 | 1,880 | 1,880 | 1,855 | 1,862 | -13 | -0.7% | 99,300 |
| 2022/07/12 | 1,864 | 1,877 | 1,847 | 1,875 | -2 | -0.1% | 140,900 |
| 2022/07/11 | 1,867 | 1,880 | 1,854 | 1,877 | +18 | +1% | 156,100 |
| 2022/07/08 | 1,870 | 1,871 | 1,845 | 1,859 | -7 | -0.4% | 166,300 |
| 2022/07/07 | 1,868 | 1,871 | 1,854 | 1,866 | +15 | +0.8% | 126,500 |
| 2022/07/06 | 1,838 | 1,860 | 1,825 | 1,851 | +20 | +1.1% | 122,100 |
| 2022/07/05 | 1,823 | 1,839 | 1,818 | 1,831 | +8 | +0.4% | 115,000 |
| 2022/07/04 | 1,827 | 1,834 | 1,810 | 1,823 | +40 | +2.2% | 123,100 |
| 2022/07/01 | 1,789 | 1,814 | 1,773 | 1,783 | -1 | -0.1% | 120,700 |
| 2022/06/30 | 1,778 | 1,799 | 1,778 | 1,784 | +19 | +1.1% | 118,400 |
| 2022/06/29 | 1,746 | 1,775 | 1,738 | 1,765 | +9 | +0.5% | 211,600 |
| 2022/06/28 | 1,731 | 1,756 | 1,723 | 1,756 | -1 | -0.1% | 120,100 |
| 2022/06/27 | 1,766 | 1,768 | 1,737 | 1,757 | +3 | +0.2% | 118,100 |
| 2022/06/24 | 1,714 | 1,758 | 1,707 | 1,754 | +61 | +3.6% | 139,800 |
| 2022/06/23 | 1,652 | 1,712 | 1,652 | 1,693 | +47 | +2.9% | 135,700 |
| 2022/06/22 | 1,641 | 1,657 | 1,635 | 1,646 | +14 | +0.9% | 83,400 |
| 2022/06/21 | 1,616 | 1,644 | 1,616 | 1,632 | +19 | +1.2% | 95,100 |
| 2022/06/20 | 1,600 | 1,616 | 1,586 | 1,613 | +27 | +1.7% | 87,500 |
| 2022/06/17 | 1,600 | 1,610 | 1,579 | 1,586 | -33 | -2% | 237,300 |
| 2022/06/16 | 1,623 | 1,642 | 1,619 | 1,619 | -4 | -0.2% | 101,700 |
| 2022/06/15 | 1,620 | 1,641 | 1,616 | 1,623 | +1 | +0.1% | 153,300 |
| 2022/06/14 | 1,605 | 1,624 | 1,605 | 1,622 | -6 | -0.4% | 68,700 |
| 2022/06/13 | 1,610 | 1,636 | 1,610 | 1,628 | +8 | +0.5% | 72,300 |
| 2022/06/10 | 1,626 | 1,642 | 1,616 | 1,620 | -31 | -1.9% | 69,700 |
| 2022/06/09 | 1,647 | 1,662 | 1,636 | 1,651 | +7 | +0.4% | 101,900 |
| 2022/06/08 | 1,633 | 1,653 | 1,621 | 1,644 | +23 | +1.4% | 80,500 |
| 2022/06/07 | 1,604 | 1,639 | 1,603 | 1,621 | +7 | +0.4% | 60,200 |
| 2022/06/06 | 1,615 | 1,626 | 1,608 | 1,614 | -16 | -1% | 89,700 |
| 2022/06/03 | 1,650 | 1,663 | 1,626 | 1,630 | -11 | -0.7% | 194,900 |
| 2022/06/02 | 1,693 | 1,693 | 1,639 | 1,641 | -62 | -3.6% | 142,600 |
| 2022/06/01 | 1,691 | 1,720 | 1,690 | 1,703 | ±0 | ±0% | 118,500 |
| 2022/05/31 | 1,709 | 1,770 | 1,695 | 1,703 | -1 | -0.1% | 244,600 |
| 2022/05/30 | 1,687 | 1,704 | 1,670 | 1,704 | +43 | +2.6% | 316,700 |
| 2022/05/27 | 1,660 | 1,674 | 1,637 | 1,661 | +41 | +2.5% | 162,200 |
| 2022/05/26 | 1,639 | 1,650 | 1,620 | 1,620 | -18 | -1.1% | 85,900 |
551～
600
件表示中 / 6825件
類似銘柄と比較する
現在ご覧いただいている「栄研化」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 栄研化 | 232,200円 | +7.6% | +57.5% | 2.28% | 17.95倍 | 1.76倍 |
|
臨床検査薬大手。便潜血検査試薬（ＦＩＴ）はシェア７割。尿検査（ウロ）、遺伝子検査も育成 |
| ネクセラファーマ | 121,300円 | +197.7% | - | 0.00% | 49.57倍 | 1.58倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
| 杏林製薬 | 151,800円 | +3.2% | +4.5% | 3.43% | 17.44倍 | 0.67倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
| ＪＣＲファーマ | 67,900円 | -3.7% | -36.7% | 2.95% | 23.03倍 | 1.51倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
| サンバイオ | 101,300円 | - | - | 0.00% | - | 51.01倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
市場注目の銘柄
チャート関連のコラム
